샘플 요청 목록

 카트 문의
시장보고서
상품코드
1784825

세계의 동물용 스텐트 시장

Veterinary Stents
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 235 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 동물용 스텐트 시장은 2030년까지 7,570만 달러에 이를 전망

2024년에 5,220만 달러로 추정되는 동물용 스텐트 세계 시장은 2024-2030년간 CAGR 6.4%로 성장하여 2030년에는 7,570만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 기도 스텐트는 CAGR 7.9%를 나타내고, 분석 기간 종료시에는 3,900만 달러에 이를 것으로 예측됩니다. 요도 스텐트부문의 성장률은 분석 기간중 CAGR 4.4%로 추정됩니다.

미국 시장은 1,370만 달러로 추정, 중국은 CAGR6.2%로 성장 예측

미국의 동물용 스텐트 시장은 2024년에 1,370만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 6.2%로 2030년까지 1,210만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 6.1%와 5.3%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.0%를 보일 전망입니다.

세계의 동물용 스텐트 시장 - 주요 동향 및 촉진요인 정리

동물용 스텐트가 동물 건강관리에 필수적인 이유는 무엇일까?

동물용 스텐트는 동물의 기관허탈, 요도폐쇄, 심혈관 이상, 담도폐쇄 등 다양한 증상의 치료에 필수적인 도구로 등장했습니다. 수의학이 발전함에 따라, 스텐트 삽입은 기존의 외과적 개입을 대체할 수 있는 최소 침습적 대안이 되었고, 이전에는 대규모의 위험도가 높은 시술이 필요했던 질환을 장기적으로 완화할 수 있게 되었습니다. 기관허탈은 특히 요크셔 테리어나 포메라니안과 같은 소형견종에서 많이 발생하는데, 스텐트는 즉각적으로 기도를 확보하여 호흡을 개선하기 때문에 스텐트 도입의 큰 원동력이 되고 있습니다. 마찬가지로 요도 스텐트 및 담도 스텐트는 반려동물과 가축의 폐쇄성 질환 치료를 획기적으로 변화시켜 막힌 통로를 장기간에 걸쳐 개방할 수 있게 했습니다. 수의심장학도 특히 폐동맥 협착증과 같은 선천성 심장질환의 치료에서 스텐트 삽입술의 혜택을 누리고 있습니다. 회복에 걸리는 시간과 시술의 위험을 줄이는 최소침습적 기술이 강조되면서 동물용 스텐트는 현대 동물의료에서 점점 더 중요한 역할을 하고 있으며, 복잡한 질병을 앓고 있는 동물들의 삶의 질을 향상시키고 있습니다.

동물용 스텐트 기술의 최신 발전은 무엇인가?

동물용 스텐트 시장은 괄목할 만한 기술적 진보를 이뤄냈으며, 이러한 기구의 안전성, 내구성, 유효성을 향상시키고 있습니다. 가장 주목할 만한 기술 혁신 중 하나는 외과적 개입 없이 해부학적 구조에 맞는 자가 확장형 니티놀 스텐트 개발입니다. 이 스텐트는 유연성이 뛰어나 이동의 위험을 줄이고 딱딱한 스텐트에 따른 합병증을 최소화할 수 있습니다. 생분해성 스텐트도 특히 장기적인 스텐트 삽입이 필요하지 않은 일시적인 중재술에 유망한 대안으로 떠오르고 있습니다. 또한, 염증과 재협착을 예방하는 약물을 천천히 방출하는 약물 용출성 스텐트의 발전으로 시술 후 예후가 개선되고 있습니다. 특히 기관이나 요도에 적용하기 위해 특정 동물의 해부학적 구조에 맞춘 맞춤형 디자인의 스텐트가 인기를 끌고 있으며, 더 나은 적합성을 보장하고 불편함을 줄여주고 있습니다. 스텐트 삽입을 위한 투시 유도 및 내시경 유도 사용으로 정확도가 더욱 향상되어 수의사는 최소한의 침습으로 스텐트를 삽입할 수 있게 되었습니다. 생체재료와 수의학 중재적 방사선학 연구가 계속 발전함에 따라 수의학 분야에서 스텐트의 효과와 활용도가 크게 확대될 것으로 예측됩니다.

동물용 스텐트 보급을 가로막는 과제는 무엇일까?

동물용 스텐트의 효과는 입증되었지만, 몇 가지 문제가 동물용 스텐트의 보급을 가로막고 있습니다. 주요 장벽 중 하나는 스텐트 자체, 특수 영상 장비, 적절한 삽입에 필요한 전문 지식 등 스텐트 삽입술과 관련된 높은 비용입니다. 많은 동물병원이나 진료소에서는 필요한 중재적 영상의학 인프라가 갖추어져 있지 않아 스텐트삽입술을 받을 수 있는 곳은 시설이 잘 갖춰진 전문센터에 국한되어 있습니다. 또한, 스텐트는 막힌 상태를 즉각적으로 완화시켜 주지만, 스텐트 이동, 막힘, 조직 성장과 같은 장기적인 합병증에 대한 우려가 남아있어 지속적인 모니터링이 필요하며, 경우에 따라서는 추가적인 개입이 필요할 수 있습니다. 동물에 사용되는 대부분의 스텐트는 인체용 스텐트를 개조한 것으로, 동물용 스텐트의 크기가 표준화되어 있지 않아 이상적인 해부학적 적합성을 제공하지 못한다는 점도 문제입니다. 성공적인 스텐트 삽입과 수술 후 관리를 위해서는 전문적인 교육이 필요하기 때문에 스텐트 삽입술에 따른 학습 곡선도 도입에 제한을 주고 있습니다. 이러한 문제를 해결하기 위해서는 수의학에 특화된 스텐트 설계에 대한 추가 연구, 수의사 교육 기회 증가, 동물병원에서 중재적 영상의학 서비스의 폭넓은 활용이 필요합니다.

동물용 스텐트 시장의 주요 성장 촉진요인은 무엇인가?

동물용 스텐트 시장의 성장은 중재적 동물 의료의 발전, 반려동물 사육 증가, 최소침습적 치료 옵션에 대한 수요 증가 등 여러 가지 요인에 기인합니다. 동물의 고도의 의료 서비스를 원하는 보호자들이 늘어나면서 회복 기간을 단축하고 치료 결과를 개선하는 비수술적 솔루션에 대한 관심이 높아지고 있습니다. 특히 선천성 질환 및 노화 관련 질환의 치료용으로 기관 및 혈관 스텐트 수요에 크게 기여하고 있는 수의 순환기학 및 호흡기학 분야의 확대가 기관 및 혈관 스텐트 수요에 큰 기여를 하고 있습니다. 또한, 반려동물과 가축 모두에서 요로 질환 및 폐색 유병률이 증가함에 따라 요도 스텐트 및 담도 스텐트의 필요성이 증가하고 있습니다. 영상 처리 및 스텐트 재료의 기술 혁신은 또한 이러한 시술을 더욱 안전하고 효과적으로 만들어 시장 채택을 더욱 촉진하고 있습니다. 중재적 영상의학 시설을 갖춘 동물병원들이 늘어나면서 스텐트 삽입이 보다 친숙해졌고, 다양한 환자들에게 치료의 선택권이 넓어지고 있습니다. 수의학이 보다 덜 침습적이고 환자 친화적인 치료법으로 전환하는 가운데, 스텐트 설계와 시술의 지속적인 개선으로 장기적인 성공률이 향상됨에 따라 동물용 스텐트 시장은 크게 성장할 것으로 예측됩니다.

부문

제품 유형(기도 스텐트, 요도 스텐트, 혈관 스텐트, 기타 스텐트), 동물 유형(개, 고양이, 기타), 소재(니티놀, 생분해성 폴리머), 용도(기도 폐쇄, 요로 폐쇄, 혈관 폐쇄, 기타 용도), 최종 용도(동물 병원 및 클리닉, 기타)

조사 대상 기업 예

  • AccuPath Group Co., Ltd.
  • AbtVet(Stening Group)
  • Alibaba Group Holding Ltd.
  • Arthrex Vet Systems
  • Create Medic Co., Ltd.
  • Dextronix Animal Health
  • Infiniti Medical
  • M.I. Tech Co., Ltd.
  • NuMED For Children
  • TaeWoong Medical USA(VetSarang)
  • UltraVet Medical Devices LLC
  • VCA Animal Hospitals
  • VetMedUSA
  • VetStent
  • Medtronic
  • Boston Scientific
  • Cook Medical
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 25.08.12

Global Veterinary Stents Market to Reach US$75.7 Million by 2030

The global market for Veterinary Stents estimated at US$52.2 Million in the year 2024, is expected to reach US$75.7 Million by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Airway Stents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$39.0 Million by the end of the analysis period. Growth in the Urethral Stents segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Million While China is Forecast to Grow at 6.2% CAGR

The Veterinary Stents market in the U.S. is estimated at US$13.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.1 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Veterinary Stents Market - Key Trends & Drivers Summarized

Why Are Veterinary Stents Becoming Essential in Animal Healthcare?

Veterinary stents have emerged as a vital tool in treating a wide range of conditions, including tracheal collapse, urethral obstruction, cardiovascular anomalies, and biliary duct obstructions in animals. As veterinary medicine advances, stent placement has become a minimally invasive alternative to traditional surgical interventions, providing long-term relief for conditions that previously required extensive and high-risk procedures. Tracheal collapse, particularly common in small dog breeds such as Yorkshire Terriers and Pomeranians, has been a significant driver for the adoption of stents, as they provide immediate airway support and improve breathing. Similarly, urethral and biliary stents have transformed the treatment of obstructive diseases in both companion animals and livestock, allowing for prolonged patency of blocked passages. Veterinary cardiology has also benefited from stenting procedures, particularly in treating congenital heart defects such as pulmonic stenosis. With the growing emphasis on minimally invasive techniques that reduce recovery times and procedural risks, veterinary stents are playing an increasingly important role in modern animal healthcare, offering improved quality of life for animals suffering from complex medical conditions.

What Are the Latest Advancements in Veterinary Stent Technology?

The veterinary stents market has seen significant technological advancements, enhancing the safety, durability, and efficacy of these devices. One of the most notable innovations is the development of self-expanding nitinol stents, which conform to anatomical structures without requiring surgical intervention. These stents provide superior flexibility, reducing the risk of migration and minimizing complications associated with rigid stents. Biodegradable stents are also emerging as a promising alternative, particularly for temporary interventions where long-term stenting may not be necessary. Additionally, advancements in drug-eluting stents, which slowly release medication to prevent inflammation and restenosis, are improving post-procedural outcomes. Custom-designed stents tailored to specific animal anatomies are gaining traction, particularly for tracheal and urethral applications, ensuring a better fit and reducing discomfort. The use of fluoroscopic and endoscopic guidance for stent placement has further improved precision, allowing veterinarians to position stents with minimal invasiveness. As research in biomaterials and veterinary interventional radiology continues to evolve, the effectiveness and versatility of stents in veterinary applications are expected to expand significantly.

What Challenges Are Hindering the Widespread Adoption of Veterinary Stents?

Despite their proven efficacy, several challenges are limiting the widespread adoption of veterinary stents. One of the primary barriers is the high cost associated with stent placement procedures, including the stent itself, specialized imaging equipment, and the expertise required for proper insertion. Many veterinary clinics and hospitals lack the necessary interventional radiology infrastructure, restricting access to stenting procedures to only well-equipped specialty centers. Additionally, while stents offer immediate relief for obstructive conditions, long-term complications such as stent migration, occlusion, and tissue in-growth remain concerns that require continuous monitoring and, in some cases, additional interventions. Another challenge is the lack of standardized veterinary stent sizes, as most stents used in animals are adaptations of human stents, which may not always provide an ideal anatomical fit. The learning curve associated with stenting procedures also limits adoption, as specialized training is required to ensure successful placement and post-operative management. Addressing these challenges will require further research into veterinary-specific stent designs, increased training opportunities for veterinarians, and broader availability of interventional radiology services in veterinary hospitals.

What Are the Key Growth Drivers of the Veterinary Stents Market?

The growth in the veterinary stents market is driven by several factors, including advancements in interventional veterinary medicine, increasing pet ownership, and the rising demand for minimally invasive treatment options. As more pet owners seek advanced medical care for their animals, there is growing interest in non-surgical solutions that offer shorter recovery times and improved outcomes. The expanding field of veterinary cardiology and pulmonology has significantly contributed to the demand for tracheal and vascular stents, particularly for treating congenital and age-related conditions. Additionally, the rising prevalence of urinary tract diseases and obstructions in both companion animals and livestock has fueled the need for urethral and biliary stents. Technological innovations in imaging and stent materials have also made these procedures safer and more effective, further driving market adoption. The increasing number of veterinary specialty hospitals equipped with interventional radiology facilities is making stent placement more accessible, expanding treatment options for a wider range of patients. As veterinary medicine continues to shift toward less invasive and more patient-friendly treatment methods, the veterinary stents market is expected to experience substantial growth, with continuous improvements in stent design and procedural techniques enhancing long-term success rates.

SCOPE OF STUDY:

The report analyzes the Veterinary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Airway Stents, Urethral Stents, Vascular Stents, Other Stents); Animal Type (Dogs, Cats, Others); Material (Nitinol, Biodegradable Polymer); Application (Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions, Other Applications); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 39 Featured) -

  • AccuPath Group Co., Ltd.
  • AbtVet (Stening Group)
  • Alibaba Group Holding Ltd.
  • Arthrex Vet Systems
  • Create Medic Co., Ltd.
  • Dextronix Animal Health
  • Infiniti Medical
  • M.I. Tech Co., Ltd.
  • NuMED For Children
  • TaeWoong Medical USA (VetSarang)
  • UltraVet Medical Devices LLC
  • VCA Animal Hospitals
  • VetMedUSA
  • VetStent
  • Medtronic
  • Boston Scientific
  • Cook Medical
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Veterinary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Interventional Veterinary Procedures Drive Adoption of Minimally Invasive Stenting Solutions
    • Rising Incidence of Tracheal Collapse and Urethral Obstruction Throws the Spotlight On Specialty Stent Applications
    • Integration of Fluoroscopy and Endoscopy with Stenting Enhances Procedural Precision and Expands Use Cases
    • Increasing Pet Longevity Spurs Demand for Long-Term Palliative Solutions Such as Stents
    • Customization Capabilities in Stent Design Expands Addressable Market Opportunity for Specialized Animal Anatomy
    • Technological Innovations in Self-Expanding and Bioabsorbable Stents Propel Product Differentiation
    • Growing Popularity of Specialty Veterinary Hospitals Strengthens Business Case for Advanced Interventional Devices
    • Surge in Companion Animal Surgeries Drives Demand for Post-Operative Support Devices Including Stents
    • Improvements in Stent Material Science Generate Opportunities for Lightweight and Flexible Implant Solutions
    • Veterinary Oncologic Applications Drive Adoption of Stents for Palliative Care in Obstructive Tumors
    • Integration of 3D Printing Technology in Stent Manufacturing Spurs Rapid Prototyping and Personalized Implants
    • Collaborations Between Academic Veterinary Centers and Manufacturers Accelerate Clinical Validation of Novel Stent Designs
    • Expansion of Veterinary Training in Interventional Radiology and Cardiology Drives Procedural Uptake
    • Increase in Feline and Small Dog Urethral Disorders Propels Growth in Miniature and Species-Specific Stent Offerings
    • Regulatory Approvals and Clinical Trials for Veterinary-Specific Stents Strengthen Market Accessibility and Trust
    • Rising Pet Insurance Coverage for Advanced Procedures Encourages Use of Premium Interventional Solutions
    • Market Consolidation and Strategic Acquisitions in Veterinary Devices Expand Distribution of Niche Products like Stents
    • Increased Emphasis on Quality of Life Outcomes in Geriatric Pets Spurs Adoption of Non-Surgical Interventions
    • Surge in Cross-Species Application Research Generates Demand for Flexible, Multi-Species Stenting Platforms
    • Development of Antimicrobial and Drug-Eluting Veterinary Stents Sustains Innovation-Driven Market Growth
    • Veterinary Cardiology and Urology Advancements Propel Usage of Specialized Intraluminal Devices Across Animal Health Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Stents Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Veterinary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Airway Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Airway Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Urethral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Urethral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Stent Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Stent Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Airway Collapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Airway Collapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Urinary Tract Obstructions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Urinary Tract Obstructions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Vascular Obstructions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Vascular Obstructions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Dogs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Cats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Nitinol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Nitinol by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Biodegradable Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Biodegradable Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • JAPAN
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • CHINA
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 64: China Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • EUROPE
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Veterinary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • FRANCE
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 94: France Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: France 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • GERMANY
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • ITALY
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 114: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Italy 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • UNITED KINGDOM
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 124: UK Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: UK 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 144: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Asia-Pacific 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 154: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Rest of World 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제